FOR IMMEDIATE RELEASE

ANALIS S.A. AND ATLANTIC BIOLOGICALS DIAGNOSTICS LLC ANNOUNCE PARTNERSHIP

MIAMI, FLORIDA  February 10, 2010 --Analis s.a., Suarlée, Belgium and Atlantic Biologicals Diagnostics LLC, Miami, US announce a partnership to distribute and support the CEofix™ diagnostics line of advanced capillary electrophoresis products in the United States and Puerto Rico.

Analis s.a., a pioneer and innovator of technology in the field of capillary electrophoresis and protein analysis, has a global presence in the specialty testing of Carbohydrate Deficient Transferrin (“CDT”) for chronic alcohol abuse.  Adapted and optimized to perform on the Beckman Coulter P/ACE™ MDQ electrophoretic platform, this test is recognized as a leader in its field.  

Guy Stukkens, General Manager, Analis s.a., sees the new collaboration as “opening new perspectives in product development and building the presence of our high quality kit for the diagnosis of chronic alcohol abuse on the US market.”  

Karen L. Moody, Atlantic Biologicals Diagnostics President, adds that this relationship, “further positions us as a first choice provider of high visibility and high utility diagnostic products for the laboratory.”

Analis, s.a., is a distributor of scientific apparatus, lab instruments and reagents for laboratories and manufacturer of clinical diagnostic kits, CEofix™.

Atlantic Biologicals Diagnostics, LLC, is a national and wholesale distributor of clinical and research laboratory diagnostic products, and a sister company of Atlantic Biologicals Corporation (Miami, Florida), a national distributor and wholesaler of pharmaceuticals and unit dose products in the United States and Puerto Rico.

Contact: Erik Lahti

Business Development

Atlantic Biologicals Diagnostics, LLC

Tel: 305-690-4233 x212

Email: This email address is being protected from spam bots, you need Javascript enabled to view it

http://www.atlanticbiologicals.com 

###